While a new report from Goldman Sachs says health care is in a state of flux that most of the sector’s companies haven’t adjusted to yet, it also pinpoints four that have plenty of cash that could be put to good use for investors.
Continue reading Inside Wall Street: Four Cash-Rich Pharma Picks From Goldman Sachs
Inside Wall Street: Four Cash-Rich Pharma Picks From Goldman Sachs originally appeared on DailyFinance on Wed, 22 Sep 2010 11:30:00.
Filed Under: Company News, Columns, Investing, Health Care, Goldman Sachs , Pfizer, Stock Picks